Meta-Analysis of Cardiovascular Outcomes With Continuous Positive Airway Pressure Therapy in Patients With Obstructive Sleep Apnea
- PMID: 28651851
- DOI: 10.1016/j.amjcard.2017.05.042
Meta-Analysis of Cardiovascular Outcomes With Continuous Positive Airway Pressure Therapy in Patients With Obstructive Sleep Apnea
Abstract
Obstructive sleep apnea (OSA) is associated with increased cardiovascular morbidity and mortality. Continuous positive airway pressure (CPAP) is the main treatment of OSA. The present study explores the impact of CPAP on cardiovascular outcomes. A systematic search of electronic databases for randomized controlled trials comparing CPAP with medical therapy alone in patients with OSA who reported cardiovascular outcomes of interest was performed. The main outcome was major adverse cardiac events. Other outcomes included cardiac mortality, myocardial infarction, angina pectoris, stroke, and transient ischemic attack. Fixed effect model was used in all analyses except for subgroup analysis in which the random effect DerSimonian and Laird's model was used. Four randomized controlled trials with a total of 3,780 patients were included. Compared with medical therapy alone, CPAP use was not associated with reduced risk of major adverse cardiac events (relative risk [RR] 0.94, 95% confidence interval [CI] 0.78 to 1.15, p = 0.93, I2 = 0%) except in the subgroup that wore CPAP >4 hours (RR 0.70, 95% CI 0.52 to 0.94, p = 0.02, I2 = 0%). Furthermore, no reduction in the risk of cardiac mortality (RR 1.14, 95% CI 0.66 to 1.97, p <0.36, I2 = 2%), myocardial infarction (RR 0.96, 95% CI 0.64 to 1.44, p <0.15, I2 = 47%), angina pectoris (RR 1.16, 95% CI 0.9 to 1.50, p <0.51, I2 = 0%), stroke (RR 1.01, 95% CI 0.73 to 1.38, p <0.0.86, I2 = 0%), and transient ischemic attack (RR 1.36, 95% CI 00.69 to 2.68, p <0.24, I2 = 30%) was observed. Subgroup analysis of CPAP adherence in regards to cardiac outcomes showed that CPAP use is not associated with decreased risk of heart failure (RR 0.91, 95% CI 0.50 to 1.66, p <0.55, I2 = 0%). In conclusion, compared with medical therapy alone, utilization of CPAP in patients with OSA is not associated with improved cardiac outcomes except in patients who wore it for >4 hours.
Copyright © 2017 Elsevier Inc. All rights reserved.
Comment in
-
Review: In obstructive sleep apnea, continuous positive airway pressure does not reduce cardiovascular outcomes.Ann Intern Med. 2017 Nov 21;167(10):JC55. doi: 10.7326/ACPJC-2017-167-10-055. Ann Intern Med. 2017. PMID: 29159381 No abstract available.
Similar articles
-
Efficacy of continuous positive airway pressure (CPAP) in the prevention of cardiovascular events in patients with obstructive sleep apnea: Systematic review and meta-analysis.Sleep Med Rev. 2020 Aug;52:101312. doi: 10.1016/j.smrv.2020.101312. Epub 2020 Mar 14. Sleep Med Rev. 2020. PMID: 32248026
-
Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial.JAMA. 2012 May 23;307(20):2161-8. doi: 10.1001/jama.2012.4366. JAMA. 2012. PMID: 22618923 Clinical Trial.
-
Effect of obstructive sleep apnoea and its treatment with continuous positive airway pressure on the prevalence of cardiovascular events in patients with acute coronary syndrome (ISAACC study): a randomised controlled trial.Lancet Respir Med. 2020 Apr;8(4):359-367. doi: 10.1016/S2213-2600(19)30271-1. Epub 2019 Dec 12. Lancet Respir Med. 2020. PMID: 31839558 Clinical Trial.
-
The impact of continuous positive airway pressure therapy on cardiovascular events in patients with obstructive sleep apnoea: an updated systematic review and meta-analysis.Sleep Breath. 2024 Oct;28(5):2095-2105. doi: 10.1007/s11325-024-03107-z. Epub 2024 Jul 31. Sleep Breath. 2024. PMID: 39083193
-
Continuous positive airway pressure for adults with obstructive sleep apnea and cardiovascular disease: a meta-analysis of randomized trials.Sleep Med. 2019 Feb;54:28-34. doi: 10.1016/j.sleep.2018.09.030. Epub 2018 Oct 30. Sleep Med. 2019. PMID: 30529774
Cited by
-
Cardiorespiratory interaction with continuous positive airway pressure.J Thorac Dis. 2018 Jan;10(Suppl 1):S57-S70. doi: 10.21037/jtd.2018.01.39. J Thorac Dis. 2018. PMID: 29445529 Free PMC article. Review.
-
Moderate obstructive sleep apnea and cardiovascular outcomes in older adults: a propensity score-matched multicenter study (CPAGE-MODE study).J Clin Sleep Med. 2022 Feb 1;18(2):553-561. doi: 10.5664/jcsm.9656. J Clin Sleep Med. 2022. PMID: 34534075 Free PMC article.
-
Mandibular Advancement Device Therapy in Japanese Rugby Athletes with Poor Sleep Quality and Obstructive Sleep Apnea.Life (Basel). 2022 Aug 24;12(9):1299. doi: 10.3390/life12091299. Life (Basel). 2022. PMID: 36143335 Free PMC article.
-
Severity of obstructive sleep apnea and extension of coronary artery disease.Sleep Breath. 2019 Sep;23(3):747-752. doi: 10.1007/s11325-018-1769-5. Epub 2018 Dec 14. Sleep Breath. 2019. PMID: 30552556
-
Obstructive Sleep Apnea and Cardiovascular Disease: Where Do We Stand?Anatol J Cardiol. 2023 Jul 3;27(7):375-389. doi: 10.14744/AnatolJCardiol.2023.3307. Epub 2023 Jun 7. Anatol J Cardiol. 2023. PMID: 37284828 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources